Evado launches into Asia
Wednesday, 22 October, 2008
Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.
Evado is being distributed by local clinical research company SeerPharma.
Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.
It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.
Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
